BridgeBio Pharma, Inc. (BBIO)
66.13
-1.12
(-1.67%)
USD |
NASDAQ |
Oct 05, 16:00
66.13
0.00 (0.00%)
After-Hours: 17:49
BridgeBio Pharma Price : 66.13 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 67.10 | 68.68 | 66.23 | 67.25 | 2.646M |
| Oct 01, 2026 | 65.72 | 67.26 | 65.16 | 66.91 | 3.550M |
| Sep 30, 2026 | 66.14 | 67.32 | 65.61 | 65.80 | 2.822M |
| Sep 29, 2026 | 66.38 | 67.16 | 65.82 | 65.97 | 3.597M |
| Sep 28, 2026 | 65.07 | 67.34 | 64.36 | 66.61 | 2.969M |
| Sep 25, 2026 | 66.50 | 67.07 | 64.84 | 65.57 | 2.090M |
| Sep 24, 2026 | 65.85 | 67.30 | 65.32 | 66.28 | 4.272M |
| Sep 23, 2026 | 69.23 | 70.00 | 64.90 | 65.71 | 3.678M |
| Sep 22, 2026 | 66.90 | 69.77 | 66.61 | 69.23 | 3.783M |
| Sep 21, 2026 | 67.01 | 67.33 | 65.78 | 66.58 | 3.167M |
| Sep 18, 2026 | 67.39 | 67.56 | 66.10 | 66.61 | 4.103M |
| Sep 17, 2026 | 69.72 | 69.99 | 66.93 | 67.31 | 2.344M |
| Sep 16, 2026 | 68.52 | 69.46 | 67.10 | 68.30 | 4.786M |
| Sep 15, 2026 | 72.26 | 72.40 | 66.96 | 68.39 | 3.993M |
| Sep 14, 2026 | 72.55 | 73.67 | 72.16 | 72.38 | 1.851M |
| Sep 11, 2026 | 73.22 | 74.10 | 71.98 | 72.44 | 1.767M |
| Sep 10, 2026 | 75.27 | 75.50 | 72.12 | 72.50 | 3.065M |
| Sep 09, 2026 | 73.63 | 76.81 | 73.46 | 76.08 | 2.307M |
| Sep 08, 2026 | 73.60 | 76.34 | 73.26 | 74.76 | 2.095M |
| Sep 04, 2026 | 74.98 | 75.36 | 74.11 | 74.84 | 1.539M |
| Sep 03, 2026 | 76.43 | 76.64 | 75.20 | 75.41 | 1.098M |
| Sep 02, 2026 | 76.60 | 78.25 | 75.96 | 76.50 | 1.621M |
| Sep 01, 2026 | 76.61 | 77.45 | 76.22 | 76.57 | 1.448M |
| Aug 31, 2026 | 76.20 | 77.24 | 75.02 | 76.59 | 2.064M |
| Aug 28, 2026 | 79.99 | 80.55 | 76.34 | 76.60 | 1.922M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 219.91 |
| Ionis Pharmaceuticals, Inc. | 43.49 |
| Pfizer Inc. | 27.41 |
| BioMarin Pharmaceutical, Inc. | 57.54 |
| Vertex Pharmaceuticals, Inc. | 503.39 |
Price Related Metrics
| PS Ratio | 17.99 |
| Earnings Yield | -5.40% |
| Market Cap | 12.91B |